Literature DB >> 18650484

Pathology, clinical presentations, and outcomes of C1q nephropathy.

Alenka Vizjak1, Dusan Ferluga, Mojca Rozic, Anastazija Hvala, Jelka Lindic, Tanja Kersnik Levart, Vesna Jurcić, J Charles Jennette.   

Abstract

C1q nephropathy is an uncommon glomerular disease with characteristic features on immunofluorescence microscopy. In this report, clinicopathologic correlations and outcomes are presented for 72 patients with C1q nephropathy. The study comprised 82 kidney biopsies from 28 children and 54 adults with male preponderance (68%). Immunofluorescence microscopy showed dominant or co-dominant staining for C1q in the mesangium and occasional glomerular capillary walls. Electron-dense deposits were observed in 48 of 53 cases. Light microscopy revealed no lesions (n = 27), focal segmental glomerulosclerosis (FSGS; n = 11), proliferative glomerulonephritis (n = 20), or various other lesions (n = 14). Clinical presentations in the patients who had no lesions histology were normal urine examination (7%), asymptomatic hematuria and/or proteinuria (22%), and nephrotic syndrome (minimal change-like lesion; 63%), which frequently relapsed. All patients with FSGS presented with nephrotic syndrome. Those with proliferative glomerulonephritis usually presented with chronic kidney disease (75%) or asymptomatic urine abnormalities (20%). Of the patients with sufficient follow-up data, complete remission of the nephrotic syndrome occurred in 77% of those with a minimal change-like lesion, progression to end-stage renal disease occurred in 33% of those with FSGS, and renal disease remained stable in 57% of those with proliferative glomerulonephritis. In conclusion, this study identified two predominant clinicopathologic subsets of C1q nephropathy: (1) Podocytopathy with a minimal change-like lesion or FSGS, which typically presents with nephrotic syndrome, and (2) a typical immune complex-mediated glomerular disease that varies from no glomerular lesions to diverse forms of glomerular proliferation, which typically presents as chronic kidney disease. Clinical presentation, histology, outcomes, and presumably pathogenesis of C1q nephropathy are heterogeneous.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650484      PMCID: PMC2573004          DOI: 10.1681/ASN.2007080929

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  17 in total

1.  C1q nephropathy: a pediatric clinicopathologic study.

Authors:  S S Iskandar; M C Browning; W B Lorentz
Journal:  Am J Kidney Dis       Date:  1991-10       Impact factor: 8.860

2.  Spontaneous improvement in a case of C1q nephropathy.

Authors:  M Nishida; H Kawakatsu; H Komatsu; K Ishiwari; M Tamai; T Sawada
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 3.  Pan-nephritis (glomerulonephritis, arteriolitis, and tubulointerstitial nephritis) associated with predominant mesangial C1q deposition and hypocomplementemia: a variant type of C1q nephropathy?

Authors:  H Imai; T Yasuda; K Satoh; A B Miura; T Sugawara; Y Nakamoto
Journal:  Am J Kidney Dis       Date:  1996-04       Impact factor: 8.860

4.  Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients.

Authors:  E Jones; A Magil
Journal:  Am J Clin Pathol       Date:  1982-07       Impact factor: 2.493

5.  Distinguishing C1q nephropathy from lupus nephritis.

Authors:  Andrew Sharman; Peter Furness; John Feehally
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

6.  C1q nephropathy: a variant of focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Joshua A Schwimmer; M Barry Stokes; Samih Nasr; Robert L Seigle; Anthony M Valeri; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

7.  C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?

Authors:  A Davenport; A G Maciver; J C Mackenzie
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

8.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Kidney Dis       Date:  1985-08       Impact factor: 8.860

Review 9.  A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.

Authors:  Laura Barisoni; H William Schnaper; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 8.237

10.  Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Clin Pathol       Date:  1985-04       Impact factor: 2.493

View more
  25 in total

Review 1.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

2.  Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.

Authors:  Takashi Takei; Mitsuyo Itabashi; Takahito Moriyama; Ari Shimizu; Yuki Tsuruta; Ayami Ochi; Kayu Nakayama; Chihiro Iwasaki; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-07-21       Impact factor: 2.801

3.  C1q nephropathy in a child presenting with recurrent gross hematuria.

Authors:  Luke Taggart; Alexis Harris; Samir El-Dahr; Franca Iorember
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

4.  Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?

Authors:  Mateja Vintar Spreitzer; Alenka Vizjak; Dušan Ferluga; Rajko B Kenda; Tanja Kersnik Levart
Journal:  Pediatr Nephrol       Date:  2013-07-13       Impact factor: 3.714

5.  Usefulness of skin immunofluorescence for distinguishing SLE from SLE-like renal lesions: a pilot study.

Authors:  Ines L'Erario; Alessandra Frezzolini; Barbara Ruggiero; Ornella De Pità; Francesco Emma; Alessandra Gianviti
Journal:  Pediatr Nephrol       Date:  2010-10-13       Impact factor: 3.714

6.  Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy.

Authors:  Aditi Sinha; Cynthia C Nast; Ionut Hristea; Ashley A Vo; Stanley C Jordan
Journal:  Clin Exp Nephrol       Date:  2010-11-25       Impact factor: 2.801

7.  C1q nephropathy in children: clinical characteristics and outcome.

Authors:  Vindya N Gunasekara; Neil J Sebire; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

Review 8.  Defective complement inhibitory function predisposes to renal disease.

Authors:  Anuja Java; John Atkinson; Jane Salmon
Journal:  Annu Rev Med       Date:  2012-11-01       Impact factor: 13.739

9.  Antepartum or immediate postpartum renal biopsies in preeclampsia/eclampsia of pregnancy: new morphologic and clinical findings.

Authors:  Lei Han; Zhiling Yang; Kailong Li; Jiaqun Zou; Hongmei Li; Jian Han; Lijuan Zhou; Xiaojie Liu; Xin Zhang; Yingru Zheng; Lili Yu; Li Li
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.

Authors:  Michael Maes; Aristo Vojdani; Sunee Sirivichayakul; Decio S Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2021-03-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.